Literature DB >> 19967660

Peroxynitrite plays a key role in glomerular lesions in diabetic rats.

Hui Xiao1, Yanning Li, Jinsheng Qi, Hui Wang, Kun Liu.   

Abstract

BACKGROUND: Oxidative stress plays a crucial role in chronic complications of diabetes such as diabetic nephropathy (DN), the main cause of renal failure. In diabetes, whether peroxynitrite (ONOO(-)), generated from inducible nitric oxide synthase (iNOS) induced by tumor necrosis factor alpha (TNF-alpha), plays a primary role in the pathogenesis of glomerular lesion is not yet fully known. This study was designed to investigate the role of exaggerated ONOO(-) in glomerular lesions of diabetic rats.
METHODS: Diabetes was induced in Sprague Dawley rats by an intraperitoneal injection of streptozocin, and aminoguanidine was used as selective inhibitor of iNOS. The iNOS transcription and protein distribution and content in rat glomeruli were detected. Nitrotyrosine (NT), a specific marker of ONOO(-), was measured to represent the distribution and content of ONOO(-) in rat glomeruli. TNF-alpha level and nitric oxide (NO) content were evaluated, and the pathological changes in the rat glomeruli were observed. Biochemical indicators of renal function were also measured.
RESULTS: TNF-alpha level and NO content, iNOS expression and its protein content, and NT content increased significantly, in accordance with the pathological changes of glomerulus and renal dysfunction in the diabetes group. Aminoguanidine was found to inhibit iNOS and then reduce ONOO(-) overformation, attenuating the pathological alterations.
CONCLUSION: This study clarified clearly that exaggerated ONOO(-) formation, generated from induced iNOS may play a key role in glomerular lesions in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19967660

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  9 in total

Review 1.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

2.  NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes.

Authors:  Ling Gao; Weilu Huang; Jing Li
Journal:  Mol Cell Biochem       Date:  2013-06-26       Impact factor: 3.396

Review 3.  Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances.

Authors:  K Stadler
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Peroxynitrite-induced nitration of cyclooxygenase-2 and inducible nitric oxide synthase promotes their binding in diabetic angiopathy.

Authors:  Yanning Li; Jinsheng Qi; Kun Liu; Bin Li; Hui Wang; Jinhai Jia
Journal:  Mol Med       Date:  2010-06-30       Impact factor: 6.354

Review 5.  Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Authors:  Runa Lindblom; Gavin Higgins; Melinda Coughlan; Judy B de Haan
Journal:  Rev Diabet Stud       Date:  2015-08-10

6.  Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.

Authors:  Chih-Chun Chang; Chieh-Yu Chang; Yang-Tzu Wu; Jiung-Pang Huang; Tzung-Hai Yen; Li-Man Hung
Journal:  J Biomed Sci       Date:  2011-06-23       Impact factor: 8.410

7.  Role of nitrosative and oxidative stress in neuropathy in patients with type 2 diabetes mellitus.

Authors:  Marwan S Al-Nimer; Fakhir S Al-Ani; Fatima S Ali
Journal:  J Neurosci Rural Pract       Date:  2012-01

8.  Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy.

Authors:  Ahmed A Elmarakby; Rafik Abdelsayed; Jun Yao Liu; Mahmood S Mozaffari
Journal:  EPMA J       Date:  2010-03-13       Impact factor: 6.543

9.  Beneficial Effect of Chloroquine and Amodiaquine on Type 1 Diabetic Tubulopathy by Attenuating Mitochondrial Nox4 and Endoplasmic Reticulum Stress.

Authors:  Jun Mo Kang; Hyun Seob Lee; Junghyun Kim; Dong Ho Yang; Hye Yun Jeong; Yu Ho Lee; Dong Jin Kim; Seon Hwa Park; MinJi Sung; Jaehee Kim; Hyun Ju An; Sang Ho Lee; So Young Lee
Journal:  J Korean Med Sci       Date:  2020-09-14       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.